Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NEUVÉ Health vs No BS RX

NEUVÉ Health
Graded #254

Lower grade

vs+18.1
No BS RX
Graded #26

Higher grade

The verdict

No BS RX takes it — 82.8/100 to 64.7/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNo BS RX +43
49
92
Dose & formulationNo BS RX +15
75
90
Clinical oversightNo BS RX +3
69
72
Labs & monitoringNEUVÉ Health +5
73
68
FulfillmentNo BS RX +18
76
94
Contract termsNo BS RX +29
45
74
NEUVÉ Health · left barNo BS RX · right bar

The numbers

MetricNEUVÉ HealthNo BS RX
WeighScore64.7/10082.8/100
GradeCB−
Scorecard rank#254#26
Semaglutide$179/mo (injectable microdose with B12; the site gives three answers on whether medication is included)$179/mo month-to-month (a separate low-dose program is $140)
Tirzepatide$240/mo (injectable microdose with B12; the site gives three answers on whether medication is included)$249/mo month-to-month (a separate low-dose program is $140)
CoverageAll 50 states (claimed; the same page says members in 40+ states)Not publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
NEUVÉ Health

Graded #254 · C

Strengths

  • The whole GLP-1 catalog is built around microdosing rather than offering it as an afterthought, with an injectable and a daily sublingual route at different prices
  • Names its lab partners, Quest and LabCorp, and says panel pricing is confirmed before a charge
  • States both compounding classes on the homepage rather than leaving the question open
  • Names clinicians on the site and inside the matching step of the intake
  • A large hormone, peptide and lab menu sits beside the GLP-1 lines

Where it loses points

  • Three incompatible answers to whether medication is in the price: the weight-loss program page is headed “all-in monthly pricing” and its own fine print says medication, labs and supplies are billed separately
  • Four different “from” floors are published across four pages, one of which belongs to the testosterone line rather than the GLP-1 one
  • Three membership tiers — Core, Plus and Premium — are named once in the financial policy and priced nowhere
  • The tirzepatide sublingual microdose card lists compounded sublingual semaglutide microdose in its own inclusion list
  • Every legal page closes by saying it is plain-English summary copy under review by counsel and may change before public launch, on a site already taking intake
  • “All 50 U.S. states” and “members in 40+ states” are printed on the same homepage without the distinction the About page draws
  • Membership fees are non-refundable, and no pharmacy, medical group entity or NPI is named
No BS RX

Graded #26 · B−

Strengths

  • Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
  • "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
  • Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
  • Six programs across four terms are published with no intake and no account
  • A sleep program is priced on the same page, including a diagnostic ring study at $33/mo

Where it loses points

  • The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
  • The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
  • The Terms name four pharmacies and no operating company
  • State availability is not published, and there is no FDA-approved brand lane

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard